ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE

Hormone-receptor positive breast cancer is the most common molecular subtype and represents 60–75 % of all breast cancers (BC). The presence of specific molecular targets such as the estrogen/progesterone receptor determines the use of hormone therapy for patients with this subtype. Tamoxifen, a sel...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: D. B. Erdyneeva, N. N. Babyshkina, T. A. Dronova, S. V. Vtorushin, E. M. Slonimskaya, V. N. Stegniy, N. V. Cherdyntseva
Format: Artigo
Langue:Russo
Publié: Tomsk National Research Medical Center of the Russian Academy of Sciences 2020-09-01
Collection:Sibirskij Onkologičeskij Žurnal
Sujets:
hormone-receptor positive breast cancer
cyclin d1
tamoxifen
resistance mechanisms
Accès en ligne:https://www.siboncoj.ru/jour/article/view/1540
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires